BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20236727)

  • 1. Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid?
    Aokage K; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Lung Cancer; 2010 Nov; 70(2):163-7. PubMed ID: 20236727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].
    Ota S; Inaba H; Yoshida H
    Kyobu Geka; 2001 Dec; 54(13):1073-8; discussion 1078-81. PubMed ID: 11761888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.
    Eckardt J; Jakobsen E; Licht PB
    Ann Thorac Surg; 2017 Apr; 103(4):1121-1125. PubMed ID: 28109572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
    Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
    J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
    Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection.
    Okada M; Tsubota N; Yoshimura M; Miyamoto Y
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):949-53. PubMed ID: 9832685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis.
    Asamura H; Nakayama H; Kondo H; Tsuchiya R; Naruke T
    J Thorac Cardiovasc Surg; 1999 Jun; 117(6):1102-11. PubMed ID: 10343258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of mediastinal lymph node dissection for clinical T1 non-small cell lung cancer.
    Fujiu K; Kanno R; Suzuki H; Shio Y; Higuchi M; Ohsugi J; Yonechi A; Hasegawa T; Oishi A; Gotoh M
    Fukushima J Med Sci; 2005 Jun; 51(1):33-40. PubMed ID: 16167671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omission of mediastinal lymph node dissection in lung cancer: its techniques and diagnostic procedures.
    Nomori H; Iwatani K; Kobayashi H; Mori A; Yoshioka S
    Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):83-8. PubMed ID: 16702928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
    Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
    PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The rule of lymph node metastasis of adenosquamous carcinoma of the lung].
    Li J; Zhang DC; He J; Liu XY; Mu JW; Zhang LZ
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):524-7. PubMed ID: 19950701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival?
    Okada M; Tsubota N; Yoshimura M; Miyamoto Y; Matsuoka H
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):270-5. PubMed ID: 10425000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma.
    Niwa Y; Koike M; Hattori M; Iwata N; Takami H; Hayashi M; Tanaka C; Kobayashi D; Kanda M; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23(2):611-8. PubMed ID: 26289807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.